# Neoadjuvant Immunotherapy Plus Chemotherapy Followed by Concurrent Chemoradiotherapy and Consolidative Immunotherapy for Locally Advanced Non-small Cell Lung Ca

Source: https://onco.cc/trials/nct06734702/  
OnCo record `nct06734702` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 3 trial in lung cancer, run by Sun Yat-sen University, now recruiting.

## Summary

Neoadjuvant Immunotherapy Plus Chemotherapy Followed by Concurrent Chemoradiotherapy and Consolidative Immunotherapy for Locally Advanced Non-small Cell Lung Cancer is a phase 3, randomised interventional study registered as NCT06734702 by Sun Yat-sen University, with a registry enrolment figure of 497 participants, started 2024-11-30 and due to reach its primary completion in 2028-11-29. Interventions recorded: Neoadjuvant therapy; Hypo-RT and concurrent chemotherapy; CFRT and concurrent chemotherapy; Consolidative immunotherapy. Conditions listed: Neoadjuvant Therapy; Concurrent Chemoradiotherapy; Immunotherapy; Locally Advanced Non-Small Cell Lung Cancer. Primary outcome: Progression-Free Survival rate. Lung eligibility wording from the registry: "* Diagnosis: Patients must have locally advanced, unresectable (stage III) non-small cell lung cancer (NSCLC), with histological or cytological confirmation of the diagnosis". Sites: China. No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-25
- Tags: ctgov-ingest; lung-deep-dive
- Registry id: NCT06734702
- Phase: 3
- Setting: Neoadjuvant Immunotherapy Plus Chemotherapy Followed by Concurrent Chemoradiotherapy and Consolidative Immunotherapy Compared With Concurrent Chemoradiotherapy and Consolidative Immunotherapy in Locally Advanced Non-small Cell Lung Cancer: A Randomized, Phase III Controlled Study
- Sponsor: Sun Yat-sen University
- Enrolled: 497

## Sources

- ClinicalTrials.gov NCT06734702: https://clinicaltrials.gov/study/NCT06734702

## Connected records

- cancers: [Unresectable stage III non-small-cell lung cancer](https://onco.cc/cancers/stage-iii-unresectable-nsclc/)
- technologies: [IMRT / IGRT (modern external beam)](https://onco.cc/technologies/imrt-igrt/)
- terms: [Lung cancer trials open today (registry snapshot)](https://onco.cc/terms/lung-trials-open-today/)

---
JSON: https://onco.cc/api/v1/entities/nct06734702.json